We have previously shown that in the DEN mouse model for hepatocarcinogenesis, PHD inhibition results in a mixed HCC-CC phenotype, high in LPC characteristics, which has been associated with a worse prognosis (Heindryckx et al., 2012[16]; Bogaerts et al., 2015[1]). This evidence concerns the gene PDC and cholangiocarcinoma.